Literature DB >> 31907275

Desperately Seeking Therapies for Cerebral Malaria.

Brittany A Riggle1, Louis H Miller2, Susan K Pierce3.   

Abstract

Malaria is a deadly infectious disease caused by parasites of the Plasmodium spp. that takes an estimated 435,000 lives each year, primarily among young African children. For most children, malaria is a febrile illness that resolves with time, but in ∼1% of cases, for reasons we do not understand, malaria becomes severe and life threatening. Cerebral malaria (CM) is the most common form of severe malaria, accounting for the vast majority of childhood deaths from malaria despite highly effective antiparasite chemotherapy. Thus, CM is one of the most prevalent lethal brain diseases, and one for which we have no effective therapy. CM is, in part, an immune-mediated disease, and to fully understand CM, it is essential to appreciate the complex relationship between the malarial parasite and the human immune system. In this study, we provide a primer on malaria for immunologists and, in this context, review progress identifying targets for therapeutic intervention.

Entities:  

Mesh:

Year:  2020        PMID: 31907275      PMCID: PMC6951433          DOI: 10.4049/jimmunol.1900829

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

Review 1.  Malaria parasites and red cell variants: when a house is not a home.

Authors:  Steve M Taylor; Rick M Fairhurst
Journal:  Curr Opin Hematol       Date:  2014-05       Impact factor: 3.284

Review 2.  Cerebral malaria pathogenesis: revisiting parasite and host contributions.

Authors:  Georges Emile Raymond Grau; Alister Gordon Craig
Journal:  Future Microbiol       Date:  2012-02       Impact factor: 3.165

3.  Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration.

Authors:  G G MacPherson; M J Warrell; N J White; S Looareesuwan; D A Warrell
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

4.  Prognostic significance and course of retinopathy in children with severe malaria.

Authors:  Nicholas A Beare; Caroline Southern; Chipo Chalira; Terrie E Taylor; Malcolm E Molyneux; Simon P Harding
Journal:  Arch Ophthalmol       Date:  2004-08

5.  Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

Authors:  Terrie E Taylor; Wenjiang J Fu; Richard A Carr; Richard O Whitten; Jeffrey S Mueller; Nedson G Fosiko; Susan Lewallen; N George Liomba; Malcolm E Molyneux; Jeffrey G Mueller
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

6.  Brain MRI of children with retinopathy-negative cerebral malaria.

Authors:  Douglas G Postels; Chenxi Li; Gretchen L Birbeck; Terrie E Taylor; Karl B Seydel; Sam D Kampondeni; Simon J Glover; Michael J Potchen
Journal:  Am J Trop Med Hyg       Date:  2014-09-08       Impact factor: 2.345

7.  Inhibiting the Mammalian target of rapamycin blocks the development of experimental cerebral malaria.

Authors:  Emile B Gordon; Geoffrey T Hart; Tuan M Tran; Michael Waisberg; Munir Akkaya; Jeff Skinner; Severin Zinöcker; Mirna Pena; Takele Yazew; Chen-Feng Qi; Louis H Miller; Susan K Pierce
Journal:  MBio       Date:  2015-06-02       Impact factor: 7.867

8.  The murine cerebral malaria phenomenon.

Authors:  Nicholas J White; Gareth D H Turner; Isabelle M Medana; Arjen M Dondorp; Nicholas P J Day
Journal:  Trends Parasitol       Date:  2009-11-22

9.  The machinery underlying malaria parasite virulence is conserved between rodent and human malaria parasites.

Authors:  Mariana De Niz; Ann-Katrin Ullrich; Arlett Heiber; Alexandra Blancke Soares; Christian Pick; Ruth Lyck; Derya Keller; Gesine Kaiser; Monica Prado; Sven Flemming; Hernando Del Portillo; Chris J Janse; Volker Heussler; Tobias Spielmann
Journal:  Nat Commun       Date:  2016-05-26       Impact factor: 14.919

Review 10.  Structure-Function Relationship of Transporters in the Glutamate-Glutamine Cycle of the Central Nervous System.

Authors:  Mariko Kato Hayashi
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923

View more
  5 in total

1.  Malaria parasite heme biosynthesis promotes and griseofulvin protects against cerebral malaria in mice.

Authors:  Manjunatha Chandana; Aditya Anand; Sourav Ghosh; Rahul Das; Subhashree Beura; Sarita Jena; Amol Ratnakar Suryawanshi; Govindarajan Padmanaban; Viswanathan Arun Nagaraj
Journal:  Nat Commun       Date:  2022-07-12       Impact factor: 17.694

2.  Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation.

Authors:  Jacob Golenser; Nadeen Salaymeh; Abd Alroof Higazi; Mohammed Alyan; Mahran Daif; Ron Dzikowski; Abraham J Domb
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810

3.  Co-infection of hepatitis E virus and Plasmodium falciparum malaria: A genuine risk in sub-Saharan Africa.

Authors:  Syeda Sahra; Abdullah Jahangir; Qasim Zafar Iqbal; Neville Mobarakai; Allison Glaser; Ahmad Jahangir
Journal:  Parasit Vectors       Date:  2021-04-20       Impact factor: 3.876

Review 4.  Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials.

Authors:  Hu Qian; Zhimin Ye; Lanping Pi; Jun Ao
Journal:  Mater Today Bio       Date:  2022-09-06

5.  Testing the impact of a single nucleotide polymorphism in a Plasmodium berghei ApiAP2 transcription factor on experimental cerebral malaria in mice.

Authors:  Munir Akkaya; Abhisheka Bansal; Patrick W Sheehan; Mirna Pena; Clare K Cimperman; Chen Feng Qi; Takele Yazew; Thomas D Otto; Oliver Billker; Louis H Miller; Susan K Pierce
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.